Nutex Health Inc. (NASDAQ: NUTX) extended its authorized share‑repurchase program on December 4 2025, adding a six‑month period that will run through March 31 2026. The extension builds on the $25 million repurchase authorization approved on August 14 2025 and is executed under a Rule 10b‑18 and Rule 10b‑5‑1 trading plan that became effective on the same day.
The company’s board emphasized that the buyback is a tool to return excess capital to shareholders while maintaining flexibility to fund its micro‑hospital expansion. Nutex reported $166 million in cash on hand and $177.7 million in nine‑month operating cash flow, figures that underscore a strong liquidity position and low long‑term debt. The program is not mandatory; the number of shares repurchased will depend on market conditions, earnings, and capital needs.
Nutex’s Q3 2025 results—released on November 19—showed a 240% year‑over‑year revenue increase to $267.8 million, driven by robust demand for inpatient services at its newly opened and ramping hospitals. Gross margin rose to 55.01% and operating margin to 36.59%, reflecting efficient cost management and a favorable mix of high‑margin services. The company also turned a net loss into a net income, signaling improved profitability.
Management highlighted that the share‑repurchase program will offset dilution from stock‑compensation issuances tied to under‑construction hospitals. By extending the buyback window, Nutex signals confidence in its cash generation and its ability to support future growth without compromising shareholder returns. The program aligns with the company’s strategy of expanding its micro‑hospital network while maintaining a disciplined capital structure.
The extension reinforces Nutex’s commitment to shareholder value and its broader strategy of scaling a high‑margin, patient‑centric healthcare model. With a solid cash position, low debt, and a track record of accelerating revenue growth, the company is positioned to execute the buyback when market conditions and earnings allow, while continuing to invest in its expanding network.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.